Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
No price history available for this symbol yet.
No one on the platform currently holds MSCL.TO.
No tracked institution reports a position in MSCL.TO as of their last filing.
No one on the platform has traded MSCL.TO yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $0 | — | $-2.24 | $-2.43–$-2.05 | — | 2 |
| 2027 | $0 | — | $-2.14 | $-2.14–$-2.14 | — | 2 |
| 2028 | $4M | — | $-2.02 | $-2.40–$-1.65 | — | 2 |
| 2029 | $0 | -100.0% | $-1.67 | $-1.67–$-1.67 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 4 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-13 | $-0.72 | $-0.55 | +24.2% |
| 2026-05-19 | $-0.68 | $-0.73 | -8.0% |
| 2026-03-27 | $-0.52 | $-0.69 | -34.2% |
| 2025-11-14 | $-0.45 | $-0.42 | +8.1% |
| 2025-08-13 | $-0.37 | $-0.39 | -7.5% |
| 2025-05-13 | $-0.05 | $-0.04 | +20.0% |
| 2025-03-26 | $-0.04 | $-0.05 | -25.0% |
| 2024-11-13 | $-0.05 |
| $-0.05 |
| +0.0% |
| +5.88% |
| $137M |
| — |
| LOVE.VCannara Biotech Inc. | $1.89 | +6.18% | $181M | — |
| MDNA.TOMedicenna Therapeutics Corp. | $0.40 | -1.23% | $31M | — |
Source: Financial Modeling Prep · peers by sector/industry